Cytogenetic Subclone Burden: A New Biomarker Predicting Chronic Lymphocytic Leukemia Patients Outcome.

Salah ArefMona MansourSherin Abdel-AzizMohamed SabryMohamed ArefWesam El Dosoky

Published in: Asian Pacific journal of cancer prevention : APJCP (2024)

Quantification of 17pdel burden (>vs.≤33%) could be used for refining risk stratification of CLL patients.

Keyphrases